Sit Investment Associates’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.16M Buy
+271,270
New +$3.9M 0.08% 221
2025
Q2
Sell
-1,496,158
Closed -$22.3M 526
2025
Q1
$22.3M Sell
1,496,158
-228,548
-13% -$3.58M 0.52% 46
2024
Q4
$24.8M Buy
1,724,706
+125,599
+8% +$1.94M 0.56% 41
2024
Q3
$25.3M Sell
1,599,107
-93,467
-6% -$1.47M 0.57% 48
2024
Q2
$26M Buy
1,692,574
+29,764
+2% +$451K 0.6% 48
2024
Q1
$27.3M Buy
1,662,810
+1,181,677
+246% +$18.6M 0.63% 41
2023
Q4
$7.05M Buy
+481,133
New +$6.72M 0.17% 172

Other funds holding BMEZ

Sit Investment Associates's BMEZ Position: Q2 2026 in Review

Sit Investment Associates opened a new position in BlackRock Health Sciences Trust II (BMEZ) in Q2 2026: 271,270 shares worth $4.16M. The stake represents 0.08% of the portfolio and ranks #221 among its holdings. This is a return to the name: Sit Investment Associates previously reported a position in BMEZ as recently as Q1 2025.

Sit Investment Associates first reported a position in BMEZ in Q4 2023 and has held it in 7 quarters since. The position peaked at $27.3M in Q1 2024. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Sit Investment Associates held 271,270 shares of BlackRock Health Sciences Trust II worth $4.16M as of Q2 2026.
  • BlackRock Health Sciences Trust II was a new Sit Investment Associates position in Q2 2026.
  • BlackRock Health Sciences Trust II made up 0.08% of Sit Investment Associates's portfolio in Q2 2026, its #221 holding.
  • Sit Investment Associates first reported a position in BlackRock Health Sciences Trust II in Q4 2023 and has held it in 7 quarters since.
  • Sit Investment Associates's BlackRock Health Sciences Trust II position peaked at $27.3M in Q1 2024.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.